In 1996 Worth magazine proclaimed that Isis Pharmaceuticals could become the next Microsoft, a prediction that turned out to be a particularly egregious example of hyperbole run amok. To be sure, Isis remains a leader in the gene-blocking technology called antisense. But the road
to successful treatments for cancer and other diseases has been littered with
This article was originally published with the title Hitting the Genetic Off Switch.